These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 11846136)
1. Current strategies for the provision of safer plasma and its derivatives: an update. Seghatchian J; Allain JP Transfus Apher Sci; 2001 Dec; 25(3):185-7. PubMed ID: 11846136 [No Abstract] [Full Text] [Related]
2. The Dublin Consensus Statement 2011 on vital issues relating to the collection and provision of blood components and plasma-derived medicinal products. O'Mahony B; Turner A Vox Sang; 2012 Feb; 102(2):140-3. PubMed ID: 21806632 [No Abstract] [Full Text] [Related]
4. Prioritizing the options for enhancing blood component safety. Barbara J; Seghatchian J Transfus Apher Sci; 2001 Dec; 25(3):225. PubMed ID: 11846152 [No Abstract] [Full Text] [Related]
5. Validation approaches selective/universal leucodepletion: the need for standardised validation strategies. Seghatchian MJ; Krailadsiri P Transfus Sci; 1998 Dec; 19(4):363-5. PubMed ID: 10351157 [No Abstract] [Full Text] [Related]
6. How we manage AB plasma inventory in the blood center and transfusion service. Yazer M; Eder AF; Land KJ Transfusion; 2013 Aug; 53(8):1627-33. PubMed ID: 23614505 [TBL] [Abstract][Full Text] [Related]
7. [Erythrocyte transfusion: update of the guidelines "therapy with blood components and plasma derivatives"]. Welte M Anaesthesist; 2009 Nov; 58(11):1150-8. PubMed ID: 19838643 [TBL] [Abstract][Full Text] [Related]
8. Operational and research approaches to universal leucodepletion in Scotland. Prowse C Transfus Sci; 1998 Dec; 19(4):367-9. PubMed ID: 10351158 [No Abstract] [Full Text] [Related]
10. International views on universal leucodepletion: the perspective in The Netherlands. de Wit HC Transfus Sci; 1998 Dec; 19(4):353-4. PubMed ID: 10351153 [No Abstract] [Full Text] [Related]
11. Reasons for moving toward a patient-centric paradigm of clinical transfusion medicine practice. Vamvakas EC Transfusion; 2013 Apr; 53(4):888-901. PubMed ID: 22882177 [TBL] [Abstract][Full Text] [Related]
13. International views on universal leucodepletion: the perspective in Germany. Seitz MD Transfus Sci; 1998 Dec; 19(4):359-60. PubMed ID: 10351155 [No Abstract] [Full Text] [Related]
14. [Transfusion of fresh coagulated plasma: products, indications. General methods and recommendations]. Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS) Transfus Clin Biol; 2002; 9(5-6):322-32. PubMed ID: 12555750 [No Abstract] [Full Text] [Related]
15. [Therapy with blood components and plasma derivatives: the current cross-sectional guidelines]. Biscoping J Anaesthesist; 2009 Nov; 58(11):1083-4. PubMed ID: 19890616 [No Abstract] [Full Text] [Related]
16. Plasma components: FFP, FP24, and thawed plasma. Eder AF; Sebok MA Immunohematology; 2007; 23(4):150-7. PubMed ID: 18284305 [No Abstract] [Full Text] [Related]
17. The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children. Stanworth SJ; Grant-Casey J; Lowe D; Laffan M; New H; Murphy MF; Allard S Transfusion; 2011 Jan; 51(1):62-70. PubMed ID: 20804532 [TBL] [Abstract][Full Text] [Related]